A detailed history of New York State Common Retirement Fund transactions in Neogenomics Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 36,428 shares of NEO stock, worth $575,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,428
Previous 103,528 64.81%
Holding current value
$575,198
Previous $1.44 Million 62.6%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$13.4 - $17.73 $899,140 - $1.19 Million
-67,100 Reduced 64.81%
36,428 $537,000
Q2 2024

Jul 31, 2024

BUY
$13.01 - $15.77 $226,230 - $274,224
17,389 Added 20.19%
103,528 $1.44 Million
Q1 2024

May 07, 2024

BUY
$14.06 - $16.79 $99,080 - $118,319
7,047 Added 8.91%
86,139 $1.35 Million
Q4 2023

Feb 01, 2024

SELL
$11.67 - $20.73 $57,999 - $103,028
-4,970 Reduced 5.91%
79,092 $1.28 Million
Q3 2023

Nov 07, 2023

SELL
$12.15 - $17.85 $1.59 Million - $2.34 Million
-131,134 Reduced 60.94%
84,062 $1.03 Million
Q2 2023

Aug 07, 2023

SELL
$14.1 - $19.83 $600,462 - $844,480
-42,586 Reduced 16.52%
215,196 $3.46 Million
Q1 2023

May 02, 2023

BUY
$9.09 - $19.45 $1.24 Million - $2.66 Million
136,667 Added 112.84%
257,782 $4.49 Million
Q4 2022

Jan 30, 2023

BUY
$6.45 - $12.07 $19,846 - $37,139
3,077 Added 2.61%
121,115 $1.12 Million
Q3 2022

Nov 08, 2022

BUY
$7.86 - $12.91 $63,799 - $104,790
8,117 Added 7.38%
118,038 $1.02 Million
Q2 2022

Aug 04, 2022

SELL
$7.06 - $13.97 $3.23 Million - $6.39 Million
-457,346 Reduced 80.62%
109,921 $896,000
Q1 2022

May 05, 2022

SELL
$12.15 - $35.28 $3.05 Million - $8.85 Million
-250,862 Reduced 30.66%
567,267 $6.89 Million
Q4 2021

Feb 02, 2022

SELL
$30.49 - $48.49 $4.86 Million - $7.73 Million
-159,384 Reduced 16.31%
818,129 $27.9 Million
Q3 2021

Nov 02, 2021

SELL
$41.66 - $52.52 $470,133 - $592,688
-11,285 Reduced 1.14%
977,513 $47.2 Million
Q2 2021

Aug 02, 2021

SELL
$36.62 - $51.69 $24,718 - $34,890
-675 Reduced 0.07%
988,798 $44.7 Million
Q1 2021

May 11, 2021

BUY
$41.56 - $59.88 $584,624 - $842,331
14,067 Added 1.44%
989,473 $47.7 Million
Q4 2020

Feb 08, 2021

SELL
$36.08 - $56.47 $251,044 - $392,918
-6,958 Reduced 0.71%
975,406 $52.5 Million
Q3 2020

Nov 05, 2020

SELL
$33.26 - $40.48 $39,912 - $48,575
-1,200 Reduced 0.12%
982,364 $36.2 Million
Q2 2020

Aug 07, 2020

BUY
$24.21 - $31.02 $3.94 Million - $5.04 Million
162,583 Added 19.8%
983,564 $30.5 Million
Q1 2020

May 06, 2020

SELL
$20.5 - $34.53 $274,925 - $463,081
-13,411 Reduced 1.61%
820,981 $22.7 Million
Q4 2019

Feb 05, 2020

BUY
$18.96 - $29.84 $2.45 Million - $3.86 Million
129,253 Added 18.33%
834,392 $24.4 Million
Q3 2019

Nov 07, 2019

BUY
$19.12 - $26.24 $1.67 Million - $2.29 Million
87,289 Added 14.13%
705,139 $13.5 Million
Q2 2019

Aug 09, 2019

BUY
$19.57 - $24.1 $1.56 Million - $1.92 Million
79,617 Added 14.79%
617,850 $13.6 Million
Q1 2019

May 08, 2019

SELL
$12.14 - $20.46 $157,140 - $264,834
-12,944 Reduced 2.35%
538,233 $11 Million
Q4 2018

Feb 08, 2019

SELL
$11.24 - $18.5 $78,713 - $129,555
-7,003 Reduced 1.25%
551,177 $6.95 Million
Q3 2018

Nov 07, 2018

SELL
$12.5 - $15.38 $1.59 Million - $1.96 Million
-127,349 Reduced 18.58%
558,180 $8.57 Million
Q2 2018

Aug 10, 2018

BUY
$7.99 - $14.05 $48,339 - $85,002
6,050 Added 0.89%
685,529 $8.99 Million
Q1 2018

May 10, 2018

SELL
$7.23 - $8.76 $199,909 - $242,214
-27,650 Reduced 3.91%
679,479 $5.55 Million
Q4 2017

Feb 13, 2018

SELL
$8.02 - $11.18 $253,849 - $353,869
-31,652 Reduced 4.28%
707,129 $6.27 Million
Q3 2017

Nov 06, 2017

BUY
$9.11 - $11.26 $995,221 - $1.23 Million
109,245 Added 17.35%
738,781 $8.22 Million
Q2 2017

Aug 11, 2017

BUY
N/A
629,536
629,536 $5.64 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.99B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.